Logo image of MPLN

MULTIPLAN CORP (MPLN) Stock Fundamental Analysis

NYSE:MPLN - New York Stock Exchange, Inc. - US62548M2098 - Common Stock - Currency: USD

19.61  -9.59 (-32.84%)

After market: 19.61 0 (0%)

Fundamental Rating

3

Taking everything into account, MPLN scores 3 out of 10 in our fundamental rating. MPLN was compared to 39 industry peers in the Health Care Technology industry. MPLN has a medium profitability rating, but doesn't score so well on its financial health evaluation. MPLN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MPLN has reported negative net income.
MPLN had a positive operating cash flow in the past year.
MPLN had negative earnings in 4 of the past 5 years.
MPLN had a positive operating cash flow in 4 of the past 5 years.
MPLN Yearly Net Income VS EBIT VS OCF VS FCFMPLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

1.2 Ratios

MPLN has a Return On Assets (-28.94%) which is in line with its industry peers.
MPLN has a worse Return On Equity (-741.59%) than 83.78% of its industry peers.
MPLN has a better Return On Invested Capital (1.95%) than 78.38% of its industry peers.
MPLN had an Average Return On Invested Capital over the past 3 years of 3.20%. This is below the industry average of 6.44%.
Industry RankSector Rank
ROA -28.94%
ROE -741.59%
ROIC 1.95%
ROA(3y)-2.62%
ROA(5y)-2.8%
ROE(3y)-11%
ROE(5y)-10.57%
ROIC(3y)3.2%
ROIC(5y)N/A
MPLN Yearly ROA, ROE, ROICMPLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

MPLN has a better Operating Margin (13.43%) than 94.59% of its industry peers.
The Gross Margin of MPLN (74.23%) is better than 83.78% of its industry peers.
MPLN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.43%
PM (TTM) N/A
GM 74.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.58%
GM growth 5YN/A
MPLN Yearly Profit, Operating, Gross MarginsMPLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPLN is destroying value.
There is no outstanding debt for MPLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MPLN Yearly Shares OutstandingMPLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200M 400M 600M
MPLN Yearly Total Debt VS Total AssetsMPLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

MPLN has an Altman-Z score of -0.23. This is a bad value and indicates that MPLN is not financially healthy and even has some risk of bankruptcy.
MPLN has a Altman-Z score (-0.23) which is in line with its industry peers.
The Debt to FCF ratio of MPLN is 91.00, which is on the high side as it means it would take MPLN, 91.00 years of fcf income to pay off all of its debts.
MPLN's Debt to FCF ratio of 91.00 is in line compared to the rest of the industry. MPLN outperforms 56.76% of its industry peers.
A Debt/Equity ratio of 21.73 is on the high side and indicates that MPLN has dependencies on debt financing.
MPLN's Debt to Equity ratio of 21.73 is on the low side compared to the rest of the industry. MPLN is outperformed by 83.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 21.73
Debt/FCF 91
Altman-Z -0.23
ROIC/WACC0.32
WACC6.16%
MPLN Yearly LT Debt VS Equity VS FCFMPLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.3 Liquidity

MPLN has a Current Ratio of 1.05. This is a normal value and indicates that MPLN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, MPLN is not doing good in the industry: 62.16% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that MPLN should not have too much problems paying its short term obligations.
MPLN has a worse Quick ratio (1.05) than 62.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
MPLN Yearly Current Assets VS Current LiabilitesMPLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

MPLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1003.17%.
EPS 1Y (TTM)-1003.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.9%

3.2 Future

The Earnings Per Share is expected to grow by 36.42% on average over the next years. This is a very strong growth
MPLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.62% yearly.
EPS Next Y86.35%
EPS Next 2Y36.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.16%
Revenue Next 2Y2.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MPLN Yearly Revenue VS EstimatesMPLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MPLN Yearly EPS VS EstimatesMPLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MPLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MPLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPLN Price Earnings VS Forward Price EarningsMPLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

MPLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MPLN is cheaper than 94.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MPLN is valued cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.38
EV/EBITDA 8.54
MPLN Per share dataMPLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as MPLN's earnings are expected to grow with 36.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MPLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MULTIPLAN CORP

NYSE:MPLN (2/25/2025, 8:04:01 PM)

After market: 19.61 0 (0%)

19.61

-9.59 (-32.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-06 2025-05-06
Inst Owners47.86%
Inst Owner Change-99.1%
Ins Owners6%
Ins Owner Change0.33%
Market Cap317.09M
Analysts77.78
Price Target11.05 (-43.65%)
Short Float %5.02%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-770.47%
Min EPS beat(2)-1467.36%
Max EPS beat(2)-73.58%
EPS beat(4)2
Avg EPS beat(4)-371.46%
Min EPS beat(4)-1467.36%
Max EPS beat(4)45.02%
EPS beat(8)4
Avg EPS beat(8)-430%
EPS beat(12)5
Avg EPS beat(12)-285.56%
EPS beat(16)9
Avg EPS beat(16)-170.55%
Revenue beat(2)0
Avg Revenue beat(2)-5.08%
Min Revenue beat(2)-6.88%
Max Revenue beat(2)-3.29%
Revenue beat(4)0
Avg Revenue beat(4)-4.78%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)-3.13%
Revenue beat(8)2
Avg Revenue beat(8)-2.45%
Revenue beat(12)4
Avg Revenue beat(12)-2.76%
Revenue beat(16)7
Avg Revenue beat(16)15.62%
PT rev (1m)8.33%
PT rev (3m)-63.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.33%
EPS NY rev (1m)0%
EPS NY rev (3m)31.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF 6.38
P/OCF 1.88
P/B 1.53
P/tB N/A
EV/EBITDA 8.54
EPS(TTM)-66.19
EYN/A
EPS(NY)-9.03
Fwd EYN/A
FCF(TTM)3.07
FCFY15.68%
OCF(TTM)10.44
OCFY53.22%
SpS58.29
BVpS12.84
TBVpS-282.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.94%
ROE -741.59%
ROCE 2.47%
ROIC 1.95%
ROICexc 1.99%
ROICexgc 38.28%
OM 13.43%
PM (TTM) N/A
GM 74.23%
FCFM 5.27%
ROA(3y)-2.62%
ROA(5y)-2.8%
ROE(3y)-11%
ROE(5y)-10.57%
ROIC(3y)3.2%
ROIC(5y)N/A
ROICexc(3y)3.3%
ROICexc(5y)N/A
ROICexgc(3y)101.26%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.58%
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 21.73
Debt/FCF 91
Debt/EBITDA 8.11
Cap/Depr 27.69%
Cap/Sales 12.63%
Interest Coverage 0.4
Cash Conversion 30.33%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z -0.23
F-Score3
WACC6.16%
ROIC/WACC0.32
Cap/Depr(3y)22.91%
Cap/Depr(5y)20.73%
Cap/Sales(3y)9.07%
Cap/Sales(5y)8.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1003.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157%
EPS Next Y86.35%
EPS Next 2Y36.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.9%
Revenue Next Year1.16%
Revenue Next 2Y2.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.22%
EBIT Next 3Y54.92%
EBIT Next 5YN/A
FCF growth 1Y-82.64%
FCF growth 3Y-41.03%
FCF growth 5YN/A
OCF growth 1Y-55.36%
OCF growth 3Y-23.09%
OCF growth 5YN/A